| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2014↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.7B | $0.9B | $0.7B | $-1.2B | $0.7B | $0.1B | $0.9B | $-0.3B |
| EPS (Basic) | $1.48 | $0.93 | $0.05 | $-2.41 | $1.23 | $-0.66 | $1.56 | — |
| EPS (Diluted) | $1.47 | $0.93 | $0.05 | $-2.41 | $1.22 | $-0.66 | $1.56 | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2014↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $115.1B | $88.0B | $71.6B | $51.7B | $68.1B | $81.8B | $113.1B | $67.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.5B | $0.5B | $0.5B | $1.0B | $1.0B | $1.0B | $0.8B | $1.7B |
| Total Liabilities | $102.7B | $78.3B | $63.3B | $43.9B | $57.9B | $70.7B | $102.0B | $58.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $12.4B | $9.8B | $8.3B | $7.9B | $10.3B | $11.1B | $11.0B | $9.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2014↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.1B | $-0.1B | $1.0B | $1.5B | $1.7B | $1.2B | $1.6B |
| Investing Cash Flow | $-25.9B | $-11.2B | $-14.7B | $11.2B | $3.8B | $36.5B | $-14.2B | $12.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $25.2B | $11.1B | $14.2B | $-11.4B | $-6.2B | $-37.2B | $12.8B | $-14.4B |